@ARTICLE{Montazer, author = {Shekarriz, Ramin and Montazer, Fatemeh and Alizadeh-Navaei, Reza and }, title = {Overexpression of cancer stem cell marker Lgr5 in colorectal cancer patients and association with pathologic findings}, volume = {10}, number = {4}, abstract ={Background: To determine the expression of cancer stem cell marker Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) in colorectal carcinoma samples compared to normal adjacent tissue and any possible association with clinicopathological findings. Methods: This study was performed on forty samples of cancerous colorectal tissues (case group) and their adjacent normal mucosa (control group) in Imam Khomeini Hospital (Sari, Mazandaran, Iran). Expression of Lgr5 in tissue sections was done by immunohistochemistry. Statistical analysis was carried out using SPSS software. Results: Forty colorectal cancer patients including 21 males (57.8±11.6 years) and 19 females (58.4±12.77 years) were enrolled. Lgr5 was overexpressed in tumoral samples than normal adjacent tissues (77.5% vs 27.5%, p<0.001). Also, no association was found between primary tumor, regional lymph nodes, invasion, histological type, grade, distant metastasis and IHC results. Patients with low Lgr5 expression had a better survival rate than patients with high expression but this was not statistically significant (p=0.121). Conclusion:The higher immunoreactivity of Lgr5 in colorectal cancer tissues may indicate its role as a cancer stem cell marker in tumor carcinogenesis and patient’s survival however; Lgr5 is not associated with pathological prognostic variables. }, URL = {http://caspjim.com/article-1-1697-en.html}, eprint = {http://caspjim.com/article-1-1697-en.pdf}, journal = {Caspian Journal of Internal Medicine}, doi = {10.22088/cjim.10.4.411}, year = {2019} }